- Home
- NURO vs SLXN Comparison
NURO vs SLXN Comparison
Compare NURO & SLXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NURO
- SLXN
- Stock Information
- Founded
- NURO 1996
- SLXN 2008
- Country
- NURO United States
- SLXN Israel
- Employees
- NURO N/A
- SLXN N/A
- Industry
- NURO Medical/Dental Instruments
- SLXN
- Sector
- NURO Health Care
- SLXN
- Exchange
- NURO Nasdaq
- SLXN NYSE
- Market Cap
- NURO 8.2M
- SLXN 4.3M
- IPO Year
- NURO N/A
- SLXN N/A
- Fundamental
- Price
- NURO $4.38
- SLXN $1.08
- Analyst Decision
- NURO
- SLXN Strong Buy
- Analyst Count
- NURO 0
- SLXN 1
- Target Price
- NURO N/A
- SLXN $9.00
- AVG Volume (30 Days)
- NURO 19.9K
- SLXN 31.3M
- Earning Date
- NURO 02-24-2025
- SLXN 02-25-2025
- Dividend Yield
- NURO N/A
- SLXN N/A
- EPS Growth
- NURO N/A
- SLXN N/A
- EPS
- NURO N/A
- SLXN N/A
- Revenue
- NURO $3,767,764.00
- SLXN N/A
- Revenue This Year
- NURO N/A
- SLXN N/A
- Revenue Next Year
- NURO N/A
- SLXN N/A
- P/E Ratio
- NURO N/A
- SLXN N/A
- Revenue Growth
- NURO N/A
- SLXN N/A
- 52 Week Low
- NURO $2.66
- SLXN $0.21
- 52 Week High
- NURO $4.73
- SLXN $13.56
- Technical
- Relative Strength Index (RSI)
- NURO 67.35
- SLXN N/A
- Support Level
- NURO $4.16
- SLXN N/A
- Resistance Level
- NURO $4.39
- SLXN N/A
- Average True Range (ATR)
- NURO 0.06
- SLXN 0.00
- MACD
- NURO 0.00
- SLXN 0.00
- Stochastic Oscillator
- NURO 91.56
- SLXN 0.00
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.
About SLXN BIOMOTION SCIENCES
Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.